cancer

Mary Woolley's Weekly Letter: Getting to goal

By Mary Woolley on February 7, 2019

Dear Research Advocate: During his State of the Union address, when President Trump laid out the goal of ending the HIV/AIDS epidemic in the U.S., it brought to mind the critical role research has played in making eradication even plausible. Years and years of research and development in both the public and private sectors have yielded once-unimaginable diagnostics, treatments, prevention, strategies and public health surveillance tools. Relegating this scourge to the history books – in the U.S. and also worldwide – is a worthy goal indeed. The president highlighted our nation’s legacy of making “giant leaps of science and discovery.” As we noted in our statement , we can’t assume progress...

Mary Woolley's Weekly Letter: Positioning the US for success

By Mary Woolley on January 10, 2019

Dear Research Advocate: The government remains in a partial shutdown that began on December 22, taking a mounting toll on 800,000 federal workers, including those at FDA and NSF. The Alliance for a Stronger FDA has put together a “ Shutdown Toolkit ” detailing how this ongoing impasse is affecting us all. In a similar vein, the Coalition for National Science Funding has been sharing stories on social media that focus on how the shutdown is impacting NSF-funded research and programs, stifling discovery and sending a message of ‘no public confidence’ to aspiring young scientists. Clearly, the effects of the shutdown on research are multiple, disruptive and counterproductive. This New York...

A weekly advocacy message from Mary Woolley: Vote (early or not) and advocate often

By Mary Woolley on November 1, 2018

Dear Research Advocate: After Tuesday’s election, we may or may not know the exact composition of the 116th Congress, as there are likely to be some very, very close races. But there is little doubt that the picture will be clearer than it is now when it comes to the policy dynamics next year -- and that is what our post-election briefing on Thursday, November 8 from 10:00 to 11:30 a.m. EST at AAAS (1200 New York Ave, NW in Washington, DC) is all about. Register now! If history is any guide, the magnitude of change in Congress will affect the prospects for completing unfinished business during the lame-duck session of Congress; not surprisingly, the more turnover, the harder it is to build...

Celebrating Key Steps in the Global Fight against Cancer

By Ambassador Sally G. Cowal on February 1, 2018

A tsunami of cancer threatens livelihoods across the globe, and the world is largely unprepared for its impact. The disease accounts for one out of every seven deaths worldwide – more than HIV/AIDS, tuberculosis and malaria combined . Nearly 60% of the world’s cancer cases occur in low- and middle-income countries (LMICs), and these regions account for about 65% of the world’s cancer deaths . Reducing these disparities requires comprehensive and complementary approaches, and engaging with partners. The American Cancer Society’s global cancer control team has – through in-country research and collaborative partnerships – developed responsive and sustainable initiatives around cancer...

A Weekly Advocacy Message from Mary Woolley: What Money Can Buy

By Mary Woolley on October 26, 2017

Dear Research Advocate: Americans spent $8.4 billion on Halloween in 2016 -- and no doubt will spend even more this year-- enough to fund the Agency for Healthcare Research and Quality (AHRQ) for 17+ years! What we spend to improve the quality of health care delivery represents only about 0.012% of the $3.3 trillion we spend on health care. Stats like these help place research -- in this case health services research (HSR) -- spending into perspective. (For more advocacy-relevant info, see our fact sheet .) The vision for AHRQ that Director Gopal Khanna shares in this terrific blog post underscores why a far greater investment in HSR makes strategic sense for our nation. More on what money...

Former Vice President Joe Biden is Leading the Charge to Fight Cancer

By Anna Hatch on March 13, 2017

This article is the sixth in a series highlighting the accomplishments of Research!America’s 2017 Advocacy Award honorees who will be saluted at a dinner in Washington, D.C., on March 15. More details can be found here . Nearly 1.7 million Americans were diagnosed with cancer last year. National expenditures for care are estimated to rise to $156 billion in 2020. Cancer is the second leading cause of death in the United States, claiming more than half-a-million lives each year. Joseph R. Biden, Jr., 47 th Vice President of the United States, is leading efforts to accelerate the pace of cancer research through collaboration and innovative partnerships, and has been hailed as the driving...

Advocacy Honoree Phillip Sharp Takes a Bold Approach to Treating Cancer

By Anna Hatch on February 17, 2017

This article is the fourth in a series highlighting the accomplishments of Research!America’s 2017 Advocacy Award honorees who will be saluted at a dinner in Washington, D.C., on March 15. More details can be found here . Nobel laureate Phillip A. Sharp, Ph.D., is Research!America’s recipient of the Raymond and Beverly Sackler Award for Sustained National Leadership , which honors medical and health research advocacy leaders who have been instrumental in developing and implementing a sustained advocacy program for medical and health research. Prof. Sharp is an Institute Professor at the Massachusetts Institute of Technology and serves as Chair of Stand Up To Cancer’s (SU2C) Scientific...

Highlighting Progress and the Need for Ongoing Support in the Fight against Cancer

By Dr. Margaret Foti on February 3, 2017

Ahead of World Cancer Day on February 4, the American Association for Cancer Research (AACR) would like to thank the thousands of laboratory researchers, physician-scientists, healthcare professionals and patient advocates around the globe and recognize their commitment to increasing the number of cancer survivors who are alive today. In the U.S., thanks to decades of federally funded cancer research supported by the National Institutes of Health (NIH) and the National Cancer Institute (NCI), we have seen a steady rise in the number of Americans who survive a cancer diagnosis. Our continued commitment to preventing and curing cancer comes at a time when, despite all the incredible progress...

Raising Awareness for Cancer in the LGBTQ Community

By Gwendolyn Quinn, PhD, and Matthew B. Schabath, PhD on February 2, 2017

As World Cancer Day approaches, Moffitt Cancer Center remains committed to supporting research that addresses the health care needs of LGBTQ patients who are at-risk or suffering from cancer. The lesbian, gay, bisexual, transgender and queer/questioning (LGBTQ) community, also referred to as sexual and gender minorities (SGMs), is a growing and medically underserved population in the United States. It spans all races, ethnicities, ages, socioeconomic statuses, and regions of the United States and accounts for roughly 3% to 12% of the adult population. LGBTQ individuals have higher disease risk and worse health outcomes for many diseases than heterosexual and cisgender (having a gender...

The Answer to Cancer: Brilliant Scientific Minds

By Lorraine W. Egan on February 1, 2017

Gregg Gordon was 44 and the picture of health until he suddenly became excessively tired and noticed two small bumps on his shin. A visit to his doctor led to a startling cancer diagnosis, and less than 24 hours later he was receiving chemotherapy to treat acute myeloid leukemia. When standard treatments failed, Gregg’s best hope was a bone marrow transplant, but he could not find a donor match. Fortunately, he was referred to Colleen Delaney, M.D., in Seattle, who had developed a process for expanding stem cells from umbilical cord blood for use in patients without donors. As The Washington Post reported in September 2016, the procedure was a success and Gregg has been cancer-free for five...

cancer

Mary Woolley's Weekly Letter: Getting to goal

Mary Woolley's Weekly Letter: Positioning the US for success

A weekly advocacy message from Mary Woolley: Vote (early or not) and advocate often

Celebrating Key Steps in the Global Fight against Cancer

A Weekly Advocacy Message from Mary Woolley: What Money Can Buy

Former Vice President Joe Biden is Leading the Charge to Fight Cancer

Advocacy Honoree Phillip Sharp Takes a Bold Approach to Treating Cancer

Highlighting Progress and the Need for Ongoing Support in the Fight against Cancer

Raising Awareness for Cancer in the LGBTQ Community

The Answer to Cancer: Brilliant Scientific Minds

Pages

Twitter

Tags

Blogroll

Previous Posts

Take Action

How Can I Help?

Sidebar Quote